APP and Alzheimer disease: Leskovjan et al. (2009) argued that failure to observe increased levels of Cu in plaques within APP transgenic mouse models of AD is due to inadequate time for plaques to “sink” this metal within their shorter lifespan and that this is consistent with the absence of neurodegeneration in those models (Bourassa and Miller, 2012).